206 related articles for article (PubMed ID: 12505339)
1. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.
Gray LE; Ostby J; Wilson V; Lambright C; Bobseine K; Hartig P; Hotchkiss A; Wolf C; Furr J; Price M; Parks L; Cooper RL; Stoker TE; Laws SC; Degitz SJ; Jensen KM; Kahl MD; Korte JJ; Makynen EA; Tietge JE; Ankley GT
Toxicology; 2002 Dec; 181-182():371-82. PubMed ID: 12505339
[TBL] [Abstract][Full Text] [Related]
2. Use of the laboratory rat as a model in endocrine disruptor screening and testing.
Gray LE; Wilson V; Noriega N; Lambright C; Furr J; Stoker TE; Laws SC; Goldman J; Cooper RL; Foster PM
ILAR J; 2004; 45(4):425-37. PubMed ID: 15454681
[TBL] [Abstract][Full Text] [Related]
3. Tiered screening and testing strategy for xenoestrogens and antiandrogens.
Gray LE
Toxicol Lett; 1998 Dec; 102-103():677-80. PubMed ID: 10022334
[TBL] [Abstract][Full Text] [Related]
4. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
Pickford DB
Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
[TBL] [Abstract][Full Text] [Related]
5. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
Ankley GT; Gray LE
Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061
[TBL] [Abstract][Full Text] [Related]
6. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
O'Connor JC; Cook JC; Marty MS; Davis LG; Kaplan AM; Carney EW
Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364
[TBL] [Abstract][Full Text] [Related]
8. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
[TBL] [Abstract][Full Text] [Related]
9. Cloning and in vitro expression and characterization of the androgen receptor and isolation of estrogen receptor alpha from the fathead Minnow (Pimephales promelas).
Wilson VS; Cardon MC; Thornton J; Korte JJ; Ankley GT; Welch J; Gray LE; Hartig PC
Environ Sci Technol; 2004 Dec; 38(23):6314-21. PubMed ID: 15597887
[TBL] [Abstract][Full Text] [Related]
10. Summary of reference chemicals evaluated by the fish short-term reproduction assay, OECD TG229, using Japanese Medaka, Oryzias latipes.
Onishi Y; Tatarazako N; Koshio M; Okamura T; Watanabe H; Sawai A; Yamamoto J; Ishikawa H; Sato T; Kawashima Y; Yamazaki K; Iguchi T
J Appl Toxicol; 2021 Aug; 41(8):1200-1221. PubMed ID: 33486801
[TBL] [Abstract][Full Text] [Related]
11. Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model.
Ankley GT; Jensen KM; Kahl MD; Durhan EJ; Makynen EA; Cavallin JE; Martinović D; Wehmas LC; Mueller ND; Villeneuve DL
Aquat Toxicol; 2010 Sep; 99(3):389-96. PubMed ID: 20573408
[TBL] [Abstract][Full Text] [Related]
12. A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals.
Ankley GT; Jensen KM
Environ Toxicol Chem; 2014 Nov; 33(11):2529-40. PubMed ID: 25098918
[TBL] [Abstract][Full Text] [Related]
13. Assessment of in vivo assays for endocrine disruption.
Clode SA
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
[TBL] [Abstract][Full Text] [Related]
14. Toxicity testing and endocrine disrupting chemicals.
Vandenberg LN
Adv Pharmacol; 2021; 92():35-71. PubMed ID: 34452691
[TBL] [Abstract][Full Text] [Related]
15. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
[TBL] [Abstract][Full Text] [Related]
16. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee.
Stoker TE; Parks LG; Gray LE; Cooper RL
Crit Rev Toxicol; 2000 Mar; 30(2):197-252. PubMed ID: 10759431
[TBL] [Abstract][Full Text] [Related]
17. Problems in testing and risk assessment of endocrine disrupting chemicals with regard to developmental toxicology.
Mantovani A; Stazi AV; Macrì C; Maranghi F; Ricciardi C
Chemosphere; 1999 Oct; 39(8):1293-300. PubMed ID: 10467724
[TBL] [Abstract][Full Text] [Related]
18. Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay.
O'Connor JC; Frame SR; Davis LG; Cook JC
Toxicol Sci; 1999 Sep; 51(1):44-53. PubMed ID: 10496676
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals.
Villeneuve DL; Ankley GT; Makynen EA; Blake LS; Greene KJ; Higley EB; Newsted JL; Giesy JP; Hecker M
Ecotoxicol Environ Saf; 2007 Sep; 68(1):20-32. PubMed ID: 17449096
[TBL] [Abstract][Full Text] [Related]
20. Development of a Tier I screening battery for detecting endocrine-active compounds (EACs).
Cook JC; Kaplan MA; Davis LG; O'Connor JC
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):60-8. PubMed ID: 9339481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
